Bio-Gene Technology Ltd (BGT) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.811x

Based on the latest financial reports, Bio-Gene Technology Ltd (BGT) has a cash flow conversion efficiency ratio of -0.811x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-946.61K ≈ $-669.78K USD) by net assets (AU$1.17 Million ≈ $825.57K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Bio-Gene Technology Ltd (BGT) balance sheet quality index to measure how much of total assets are equity-financed.

Bio-Gene Technology Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Bio-Gene Technology Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check BGT cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Bio-Gene Technology Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bio-Gene Technology Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
REGENCY SILVER CORP. F:ZJ9	N/A
Innovative Eyewear Inc. NASDAQ:LUCY	-0.298x
Macarthur Minerals Ltd AU:MIO	-0.005x
Professional Diversity Network Inc NASDAQ:IPDN	0.126x
21st Century Management Services Limited NSE:21STCENMGM	-0.595x
WORK Medical Technology Group LTD Ordinary Shares NASDAQ:WOK	0.427x
Sentral Mitra Informatika Tbk PT JK:LUCK	-0.026x
Helios Energy Ltd AU:HE8	-0.020x

Annual Cash Flow Conversion Efficiency for Bio-Gene Technology Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of Bio-Gene Technology Ltd from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see Bio-Gene Technology Ltd (BGT) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$1.63 Million ≈ $1.15 Million	AU$-2.54 Million ≈ $-1.80 Million	-1.563x	-58.38%
2024-06-30	AU$2.79 Million ≈ $1.97 Million	AU$-2.75 Million ≈ $-1.95 Million	-0.987x	+2.98%
2023-06-30	AU$3.22 Million ≈ $2.28 Million	AU$-3.28 Million ≈ $-2.32 Million	-1.017x	-14751.29%
2022-06-30	AU$6.27 Million ≈ $4.44 Million	AU$43.52K ≈ $30.79K	0.007x	+101.61%
2021-06-30	AU$4.25 Million ≈ $3.00 Million	AU$-1.83 Million ≈ $-1.29 Million	-0.430x	-56.90%
2020-06-30	AU$6.00 Million ≈ $4.25 Million	AU$-1.64 Million ≈ $-1.16 Million	-0.274x	+38.40%
2019-06-30	AU$4.95 Million ≈ $3.50 Million	AU$-2.20 Million ≈ $-1.56 Million	-0.445x	-29.44%
2018-06-30	AU$6.91 Million ≈ $4.89 Million	AU$-2.37 Million ≈ $-1.68 Million	-0.344x	-327.50%
2017-06-30	AU$9.07 Million ≈ $6.42 Million	AU$-729.15K ≈ $-515.92K	-0.080x	+90.93%
2016-06-30	AU$473.35K ≈ $334.92K	AU$-419.35K ≈ $-296.71K	-0.886x	-440.17%
2014-06-30	AU$290.03K ≈ $205.21K	AU$-47.57K ≈ $-33.66K	-0.164x	--

About Bio-Gene Technology Ltd

AU:BGT Australia Biotechnology

Market Cap

$4.75 Million

AU$6.71 Million AUD

Market Cap Rank

#28649 Global

#1535 in Australia

Share Price

AU$0.02

Change (1 day)

-4.35%

52-Week Range

AU$0.02 - AU$0.04

All Time High

AU$0.34